Newsroom

Oct 1, 2021

Targeted Oncology | Skin Toxicity in Cancer Treatment: A Critical Part of Cancer Supportive Care

In contrast to the innovations in cancer treatments that help drive improved survival, there are far fewer innovations targeting...

Sep 7, 2021

OnQuality Pharmaceuticals Announces Completion of Part 1 of NOVA-II Trial

- Top-line readout of clinical study results anticipated by the end of 2021 SEATTLE, Sept. 7, 2021 /PRNewswire/ -- OnQuality...

Jul 22, 2021

The Bio Report | Targeting Cancer Drug Side Effects at Their Source

Link to Episode: http://thebioreport.com/2021/07/22/targeting-cancer-drug-side-effects-at-their-source/ While great strides have been...

Jul 12, 2021

The Reorient! Podcast | Dr. Hong Tang: New Frontiers in US-China Biotech

Episode link: https://www.reorientpodcast.com/episodes/hong-tang Dr. Hong Tang is the Chief Medical Officer and co-founder of OnQuality...

Jul 12, 2021

BioTech IQ | Targeting treatment related toxicities - Michael McCullar

Mike discusses the advancements that OnQuality Pharmaceuticals is making toward to the treatment of toxicities caused by cancer...

Jun 30, 2021

Health Professional Radio I OnQuality Pharmaceuticals – Phase 2 Cancer Supportive Care Therapy For

Dr. Michael McCullar, CEO, and Dr. Hong Tang, Chief Medical Officer at OnQuality Pharmaceuticals, a clinical stage pharma company...

Jun 30, 2021

Life Science Leader I Coming Out Of Stealth Mode: What To Know And Do

By Wayne Koberstein This article draws on the experience of five company CEOs with various backgrounds and views of stealth transitions....

Jun 9, 2021

OnQuality Pharmaceuticals Announces Upcoming Presentation at 2021 BIO Digital

SEATTLE, June 9, 2021 /PRNewswire/ -- OnQuality Pharmaceuticals ("OnQuality"), a targeted cancer supportive care company developing...

Jun 3, 2021

Clinical Trials Arena I OnQuality: developing treatments to combat cancer therapy side effects

By Kezia Parkins OnQuality’s chief medical officer and co-founder Hong Tang discusses the firm’s pipeline of cancer supportive care...

May 18, 2021

OnQuality Pharmaceuticals to Present on NOVA-II Trial Evaluating OQL011 at the 2021 ASCO and MASCC

OnQuality Pharmaceuticals to Present on NOVA-II Trial Evaluating OQL011 at the 2021 ASCO and MASCC/ISOO Annual Meetings SEATTLE, May 19,...